The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.03 in the prior trading day, TherapeuticsMD Inc (NASDAQ: TXMD) closed at $0.86, down -16.50%. In other words, the price has decreased by -$16.50 from its previous closing price. On the day, 0.57 million shares were traded. TXMD stock price reached its highest trading level at $1.09 during the session, while it also had its lowest trading level at $0.7.
Ratios:
Our goal is to gain a better understanding of TXMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’24 when Collins Cooper C. bought 4,094 shares for $1.73 per share. The transaction valued at 7,099 led to the insider holds 52,016 shares of the business.
Collins Cooper C. bought 1,200 shares of TXMD for $2,039 on Aug 21 ’24. The Director now owns 47,922 shares after completing the transaction at $1.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXMD now has a Market Capitalization of 9917864 and an Enterprise Value of 10647520. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.18 while its Price-to-Book (P/B) ratio in mrq is 0.37. Its current Enterprise Value per Revenue stands at 6.671 whereas that against EBITDA is -2.343.
Stock Price History:
Over the past 52 weeks, TXMD has reached a high of $2.75, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is -36.47%, while the 200-Day Moving Average is calculated to be -50.75%.
Shares Statistics:
The stock has traded on average 20.25K shares per day over the past 3-months and 88340 shares per day over the last 10 days, according to various share statistics. A total of 11.53M shares are outstanding, with a floating share count of 11.34M. Insiders hold about 1.71% of the company’s shares, while institutions hold 29.31% stake in the company. Shares short for TXMD as of 1734048000 were 21273 with a Short Ratio of 1.05, compared to 1731628800 on 30126. Therefore, it implies a Short% of Shares Outstanding of 21273 and a Short% of Float of 0.25.
